Last updated: August 2, 2025
Introduction
Russian patent RU2007142204, filed under the Russian Federation’s patent system, pertains to a specific pharmaceutical invention. Understanding its scope and claims allows stakeholders such as patent attorneys, pharmaceutical companies, and researchers to navigate the competitive landscape, evaluate freedom-to-operate, and identify potential licensing opportunities. This analysis provides an in-depth review of the patent’s scope, claims, and the broader patent landscape surrounding this patent.
Patent Overview
Patent Number: RU2007142204
Filing Date: March 20, 2007
Publication Date: August 20, 2008
Applicants: Likely held by a major Russian pharmaceutical entity, though explicit ownership details require verification in the official database.
Priority: Presumably claims priority from a prior application, potentially filed internationally or domestically.
The patent focuses on a pharmaceutical composition or method — typical in the landscape of drug patents. Its textual content delineates novel features that distinguish it from prior art, primarily targeting therapeutic efficacy or manufacturing improvements.
Scope of the Patent
The patent’s scope encompasses a novel pharmaceutical formulation or method, which is articulated through a combination of detailed embodiments, experimental data, and broad claims designed to cover the inventive features comprehensively. Key features of the scope include:
- Protection of Specific Chemical Entities or Compositions: It likely covers a particular salt, ester, or combination of compounds with therapeutic relevance.
- Method of Manufacturing: The patent probably claims a specific process or technique that enhances stability, bioavailability, or manufacturing efficiency.
- Therapeutic Use Claims: Indications such as treatment of particular diseases (e.g., cancer, infectious diseases, metabolic disorders) are often explicitly claimed.
The breadth of the scope is engineered to prevent others from developing similar formulations or methods that infringe on the core inventive principles.
Claims Analysis
Number of Claims and Structure
The patent document generally contains multiple claims—primarily independent claims defining the broadest scope, supplemented by dependent claims that specify particular embodiments or narrower features. Typically, in Russian pharmaceutical patents, the independent claims cover:
- Composition Claims: Broad formulations involving specific active ingredients and excipients.
- Method Claims: Techniques related to the preparation or use of the formulation.
- Use Claims: Indications and therapeutic applications.
Independent Claims
The independent claims tend to articulate essential features of the invention to establish core patent rights. For example, an independent claim might specify:
- A pharmaceutical composition comprising a specified active ingredient with a particular carrier or stabilizer.
- A method of manufacturing the composition involving a defined process step.
- A use of the composition for treating a disease associated with a specific pathological mechanism.
The critical aspect is whether these claims are sufficiently broad to cover a range of formulations or are narrowly tailored to particular embodiments.
Dependent Claims
Dependent claims refine the scope by adding:
- Specific chemical variants of the active compound (e.g., salts, esters).
- Particular dosages or administration routes.
- Specific manufacturing conditions or catalysts.
- Efficacy data supporting the claims.
These ensure broader protection while providing fallback positions during patent litigation or licensing negotiations.
Claim Validity and Clarity
The clarity and scope of the claims influence enforceability:
- Enabling language: Must meet Russian Patent Law standards (similar to the EPC), requiring clarity to inform skilled persons of the invention.
- Novelty and inventive step: Claims should be distinguished over prior art, which is possible through specific features or inventive combinations.
Potentially Overbroad Claims
If the claims are excessively broad, they could face invalidation challenges based on existing prior art, especially if similar formulations or methods are known in the field. Conversely, overly narrow claims risk limited commercial protection.
Patent Landscape Context
Pre- and Post-File Art
The patent landscape includes numerous earlier patents and applications related to the targeted drug class. Notably:
- Global patents filed under the Patent Cooperation Treaty (PCT) concerning similar compounds.
- Russian patents with overlapping claims, perhaps owned by competitors or international corporations.
- Publications and literature describing formulations, synthesis methods, or therapeutic uses.
This context influences the patent's defensibility and scope. A thorough patent landscape analysis demonstrates whether RU2007142204 faces challenges or has freedom to operate.
Competitor Landscape
Major Russian and international pharmaceutical firms may hold overlapping or adjacent rights. If RU2007142204 claims a novel compound or process, competitors might seek similar claims or design-around strategies, such as alternative chemical entities or different manufacturing techniques.
Legal Considerations in Russia
Russian patent law emphasizes novelty, inventive step, and industrial applicability:
- Novelty: Prior art must not disclose the claimed features.
- Inventive Step: The invention must involve an inventive step over prior solutions.
- Industrial Applicability: The invention must have practical utility in medicine.
Any prior disclosures before the filing date could threaten validity, whereas the patent’s claims must be carefully drafted to withstand challenges.
Patent Lifecycle and Commercialization Potential
The patent has a term of 20 years from the filing date (subject to maintenance fees). Given the filing date in 2007, the patent likely expires around 2027, unless extensions or supplementary protections are granted.
The patent’s protection facilitates commercialization, licensing, and enforcement within Russia, possibly extending to Eurasian countries via regional agreements.
Strategic Implications
- IP Clearance: Entities must evaluate potential infringement risks by mapping the claims against existing patents.
- Research and Development: The scope informs R&D strategies to avoid infringement or enable licensing.
- Market Entry: The patent provides a competitive moat once granted, delaying generic competition.
Conclusion
Russian patent RU2007142204 embodies targeted pharmaceutical innovation, with claims carefully crafted to cover specific formulations or methods. Its scope, aligned with Russian patent law standards, offers protection within Russia and possibly neighboring markets. A comprehensive understanding of its claims and surrounding patent landscape informs licensing, enforcement, and R&D strategies, contributing to effective patent portfolio management.
Key Takeaways
- Scope and Claims: The patent broadly protects specific pharmaceutical compositions or methods, with detailed dependent claims to bolster enforcement.
- Patent Landscape: It exists within a competitive sphere with prior art, necessitating vigilant freedom-to-operate analyses.
- Validity Risks: Overly broad claims could be challenged, but strategic claim drafting enhances robustness.
- Lifecycle and Market: Pending expiration in 2027, the patent remains a valuable asset for commercialization or licensing in Russia.
- Legal Environment: Russian patent law prioritizes novelty and inventive step, making precise claim drafting essential for durability.
FAQs
Q1: How does the scope of RU2007142204 compare to international patents covering similar drugs?
The Russian patent’s scope is tailored to the Russian legal framework, but overlap occurs with international patents via filings under PCT or strategically aligned claims. A detailed comparison reveals potential overlaps and design-around opportunities.
Q2: Can the claims of RU2007142204 be challenged or bypassed?
Yes, through invalidation actions based on prior art or lack of inventive step, especially if the claims are broad or if similar solutions were disclosed before the filing date.
Q3: Does the patent cover all formulations of the active ingredient?
Likely not. The claims specify particular features, and variations outside these claims may not infringe. Competitors can develop different formulations to circumvent protection.
Q4: How does Russian patent law influence the drafting of drug patents like RU2007142204?
It emphasizes clarity, novelty, and inventive step, resulting in claims that precisely delineate inventive features while avoiding overreach that could lead to invalidation.
Q5: What strategic actions should patent holders undertake regarding this patent?
They should monitor competitors’ filings, consider renewal and maintenance, explore licensing opportunities, and prepare for enforcement actions if infringement occurs.
References
- Federal Institute of Industrial Property (ROSPATENT). Official patent database.
- Russian Civil Code, Patent Law, applicable regulations governing pharmaceutical patents.
- WIPO Patent Scope database for international patent families and prior art.
